Projection of Creutzfeldt-Jakob disease frequency based on cadaveric dura transplantation in Japan

Neuroepidemiology

Volumn 22, Issue 1, 2003, Pages 57-64

  Hamada, Chikuma ^a   Sadaike, Tetsuji ^b   Fukushima, Masanori ^b  

^a TOKYO UNIVERSITY OF SCIENCE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Cadaveric dura mater; Creutzfeldt Jakob disease; Incubation period; Japan; Prion disease; Projection

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DURA MATER; FEMALE; HUMAN; INCUBATION TIME; JAPAN; MAJOR CLINICAL STUDY; MALE; RISK; TRANSPLANTATION;

ADULT; BRAIN TISSUE TRANSPLANTATION; CADAVER; CREUTZFELDT-JAKOB SYNDROME; DURA MATER; FEMALE; HUMANS; INCIDENCE; JAPAN; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; RISK FACTORS; TIME FACTORS;

EID: 0037243258     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000067103     Document Type: Article

References (26)

1. Roos RP: Controlling new prion diseases. N Engl J Med 2001;344:1548-1551.
2. Brown P, Preece M, Brandel JP, Sato T, Mcshane L, Zerr I, Fletcher A, Will RG, Pocchiari M, Cashman NR, Huillard d'Aignaux J, Cervenakova L, Fradkin J, Schonberger LB, Collins SJ: Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology 2000;55:1075-1081.
3. Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, Poser S, Pocchiari M, Hofman A, Smith PG: A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996;347:921-925.
4. Sato T, Hoshi K, Yoshino H, Urata J, Nakamura Y, Yanagawa H: Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts: Japan, January 1979-May 1996. MMWR 1997;46:1066-1069.
5. Triendl R: CJD link prompts ban on brain tissue use. Nature1997;387:5.
6. Nakamura Y, Aso E, Yanagawa H: Relative risk of Creutzfeldt-Jakob disease with cadaveric dura transplantation in Japan. Neurology 1999;53:218-220.
7. Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data. New York, Wiley, 1980.
8. Cox DR, Oakes D: Analysis of Survival Data. London, Chapman & Hall, 1984.
9. Brookmeyer RL, Gail M: AIDS Epidemiology. New York, Oxford University Press, 1994.
10. SAS Institute SAS/IML Software: Changes and Enhancements through Release 6.11. Cary, SAS Institute, 1995.
11. Hoshi K, Yoshino H, Urata J, Nakamura Y, Yanagawa H, Sato T: Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts in Japan. Neurology 2000;55:718-721.
12. Janssen RS, Schonberger LB: Creutzfeldt-Jakob disease from allogeneic dura: A review of risks and safety. J Oral Maxillofac Surg 1991;49:274-275.
13. Diringer H, Braig HR: Infectivity of unconventional viruses in dura mater. Lancet 1989;i:439-440.
14. Masullo C, Pocchiari M, Macchi G, Alema G, Piazza G, Panzera MA: Transmission of Creutzfeldt-Jakob disease by dural cadaveric graft. J Neurosurg 1989;71:954-955.
15. Hannah EL, Belay ED, Gambetti P, Krause G, Parchi P, Capellari S, Hoffman RE, Schonberger LB: Creutzfeldt-Jakob disease after receipt of a previously unimplicated brand of dura mater graft. Neurology 2001;56:1080-1083.
16. Ghani AC, Ferguson NM, Donnelly CA, Anderson RM: Predicted vCJD mortality in Great Britain. Nature 2000;406:583-584.
17. Nathanson N, Wilesmith J, Griot C: Bovine spongiform encephalopathy (BSE): Causes and consequences of a common source of epidemic. Am J Epidemiol 1997;145:959-969.
18. Wilesmith JW, Ryan JB, Atkinson MJ: Bovine spongiform encephalopathy: Epidemiological studies on the origin. Vet Rec 1991;128:199-203.
19. Anderson RM, Donnelly CA, Ferguson NM, Woolhouse MEJ, Watt CJ, Udy HJ, MaWhinney S, Dunstan SP, Southwood TRE, Wilesmith JW, Ryan JBM, Hoinville LJ, Hillerton JE, Austin AR, Wells GAH: Transmission dynamics and epidemiology of BSE in British cattle. Nature 1996;382:779-788.
20. Cousens SN, Vynnycky E, Zeidler M, Will RG, Smith PG: Predicting the CJD epidemic in humans. Nature 1997;385:197-198.
21. Huillard d'Aignaux J, Cousens SN, Smith PG: Predictability of the UK variant Creutzfeldt-Jakob disease epidemic. Science 2001;294:1729-1731.
22. Huillard d'Aignaux J, Costagliola D, Maccario J, Billette de Villemeur T, Brandel JP, Deslys JP, Hauw JJ, Chaussain JL, Agid Y, Dormont D, Alperovitch A: Incubation period of Creutzfeldt-Jakob disease in human growth hormone recipients in France. Neurology 1999;53:1197-1201.
23. Tateishi J, Tashima T, Kitamoto T: Inactivation of the Creutzfeldt-Jakob disease agent. Ann Neurol 1988;24:466-467.
24. Lui KJ, Darrow WW, Rutherford GW: A model-based estimate of the mean incubation period for AIDS in homosexual men. Science 1988; 24:1333-1335.
25. Nakamura Y, Yanagawa H, Kitamoto T, Sato T: Epidemiologic features of 65 Creutzfeldt-Jakob disease patients with a history of cadaveric dura mater transplantation in Japan. Epidemiol Infect 2000;125:201-205.
26. Nakamura Y, Yanagawa H, Hoshi K, Yoshino H, Urata J, Sato T: Incidence rate of Creutzfeldt-Jakob disease in Japan. Int J Epidemiol 1999;28:130-134.